NCYT:LON
Novacyt SA
39,20 GBX
arrow_downward
−1,01%(−0,40) 1 p
16. okt, 10:38:49 GMT +1 · GBX
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NCYT põhistatistika genereerimine…
Ava
39,60 GBX
Kõrge
39,60 GBX
Madal
39,20 GBX
Turu kapit.
33,74 mln
Keskm. maht
102,63 tuh
Maht
6,82 tuh
52 näd kõrgeim
86,00 GBX
52 näd madalaim
26,60 GBX
Käibivad aktsiad
37,66 mln
Töötajate arv
228
Ava
39,60 GBX
Kõrge
39,60 GBX
Madal
39,20 GBX
Turu kapit.
33,74 mln
Keskm. maht
102,63 tuh
Maht
6,82 tuh
52 näd kõrgeim
86,00 GBX
52 näd madalaim
26,60 GBX
Käibivad aktsiad
37,66 mln
Töötajate arv
228
Uudised
Veebiallikatest ja uudistepartneritelt
The Daily News | Texas' Oldest Newspaper
·
22 minuti eest
FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York City
3D Printing Industry
·
1 tunni eest
Amaero Nets $15.7M in Nasdaq IPO but Expects to Need More Capital in 2027
Opening Bell Daily
·
21 minuti eest
Stock Market Outlook: Stock pickers are lagging the index
Yahoo Finance
·
1 tunni eest
Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains
Profiil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Teave üksuse Novacyt SA kohta